Quick Win by the Algorithm: Heska Corporation (NASDAQ: HSKA) Outstands From The Crowd With Stock Up 26.80% In 14 Days

Quick Win by the Algorithm

Heska_office_building

“On a non-GAAP basis adjusted for impacts from U.S. Tax Reform, Heska earned $0.63 per diluted share in the period, up 37.0% over the prior year period; for the full year, Heska earned $2.07 per diluted share, up 44.8% over the prior year period and in excess of our full year target. We outperformed in our key blood diagnostics lines and we exceeded our profitability targets with record gross margins, operating margins, and earnings”

Kevin Wilson, Heska’s Chief Executive Officer and President

Over the past two weeks Heska Corporation’s stock price jumped

Read More

Quick Win By The Algorithm: XOMA Reaches Agreement with Novartis, Stock Soars

Stock Prediction Quick Win

Read The Full Forecast

quick win

Quick Win by the Algorithm: TEVA Share Price Plummets, as Expected

Stock Prediction Quick Win

Read The Full Forecast

Arena Stock

ImmunoGen Stock: Expected Growth in a Volatile Industry

    The article was written by Harry Chiang, a Financial Analyst at I Know First.

ImmunoGen Stock Analysis

"Almost everybody is enthusiastic about the promise of biotechnology to cure disease and to relieve suffering" - Leon Kass, American Scientist
Summary:
  • The Birth of ImmunoGen
  • Keeping Cash Close At Hand
  • An Impressive Lead Compound
  • Major Partnerships
  • An Enthusiastic Outlook on the Future

cisco stock priceRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

VRX Shares Quick Win by the Algorithm: A Valiant Effort to Recover

Quick Win by the Algorithm

Read The Full Forecast

Quick Win

Quick Win by the Algorithm: VRX Rebounding

Quick Win By The Algorithm

Read The Full Forecast

Quick Win